MCOS

Clinical trials for MCOS explained in plain language.

Never miss a new study

Get alerted when new MCOS trials appear

Sign up with your email to follow new studies for MCOS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Can a common ADHD drug curb genetic obesity?

Disease control Recruiting now

This phase 2 trial is testing whether atomoxetine, a drug used for ADHD, can help adults with melanocortin obesity syndrome (MCOS), a genetic condition that causes severe obesity. The drug may boost a brain protein called BDNF, which is part of the pathway disrupted in MCOS. Part…

Matched conditions: MCOS

Phase: PHASE2 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control

Last updated Aug 09, 2026 00:00 UTC

MCOS

Get alerted when new MCOS trials appear

Can a common ADHD drug curb genetic obesity?